These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Requirement of H-2 heterozygosity for autoimmunity in (NZB X NZW)F1 hybrid mice. Hirose S, Ueda G, Noguchi K, Okada T, Sekigawa I, Sato H, Shirai T. Eur J Immunol; 1986 Dec; 16(12):1631-3. PubMed ID: 2949983 [Abstract] [Full Text] [Related]
3. Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide. Ferrera F, Hahn BH, Rizzi M, Anderson M, Fitzgerald J, Millo E, Indiveri F, Shi FD, Filaci G, La Cava A. Arthritis Rheum; 2007 Jun; 56(6):1945-53. PubMed ID: 17530718 [Abstract] [Full Text] [Related]
4. Contribution of the gene linked to the T cell receptor beta chain gene complex of NZW mice to the autoimmunity of (NZB x NZW)F1 mice. Hirose S, Tokushige K, Kinoshita K, Nozawa S, Saito J, Nishimura H, Shirai T. Eur J Immunol; 1991 Mar; 21(3):823-6. PubMed ID: 1826267 [Abstract] [Full Text] [Related]
5. IL-4Ralpha polymorphism in regulation of IL-4 synthesis by T cells: implication in susceptibility to a subset of murine lupus. Shiroiwa W, Tsukamoto K, Ohtsuji M, Lin Q, Ida A, Kodera S, Ohtsuji N, Nakamura K, Tsurui H, Kinoshita K, Nishimura H, Shirai T, Hirose S. Int Immunol; 2007 Feb; 19(2):175-83. PubMed ID: 17189592 [Abstract] [Full Text] [Related]
7. Transgene-mediated hyper-expression of IL-5 inhibits autoimmune disease but increases the risk of B cell chronic lymphocytic leukemia in a model of murine lupus. Wen X, Zhang D, Kikuchi Y, Jiang Y, Nakamura K, Xiu Y, Tsurui H, Takahashi K, Abe M, Ohtsuji M, Nishimura H, Takatsu K, Shirai T, Hirose S. Eur J Immunol; 2004 Oct; 34(10):2740-9. PubMed ID: 15368290 [Abstract] [Full Text] [Related]
8. Analysis of the New Zealand Black contribution to lupus-like renal disease. Multiple genes that operate in a threshold manner. Drake CG, Rozzo SJ, Hirschfeld HF, Smarnworawong NP, Palmer E, Kotzin BL. J Immunol; 1995 Mar 01; 154(5):2441-7. PubMed ID: 7868910 [Abstract] [Full Text] [Related]
9. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32). Werwitzke S, Trick D, Sondermann P, Kamino K, Schlegelberger B, Kniesch K, Tiede A, Jacob U, Schmidt RE, Witte T. Ann Rheum Dis; 2008 Feb 01; 67(2):154-61. PubMed ID: 17557887 [Abstract] [Full Text] [Related]
10. Analysis of the genetic encoding of oestradiol suppression of delayed-type hypersensitivity in (NZB x NZW) F1 mice. Carlsten H, Holmdahl R, Tarkowski A. Immunology; 1991 Jun 01; 73(2):186-90. PubMed ID: 2071164 [Abstract] [Full Text] [Related]
11. Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization. Rudofsky UH, Evans BD, Balaban SL, Mottironi VD, Gabrielsen AE. Lab Invest; 1993 Apr 01; 68(4):419-26. PubMed ID: 8479150 [Abstract] [Full Text] [Related]
12. Genetic studies on the skin lupus band test in New Zealand mice. Furukawa F, Maruyama N, Yoshida H, Hamashima Y, Hirose S, Shirai T. Clin Exp Immunol; 1985 Jan 01; 59(1):146-52. PubMed ID: 3871675 [Abstract] [Full Text] [Related]
13. Genetic and molecular genetic studies of murine and human lupus. Steinberg AD, Klinman DM, Kastner DL, Seldin MF, Gause WC, Scribner CL, Britten JL, Siegel JN, Mountz JD. J Rheumatol Suppl; 1987 Jun 01; 14 Suppl 13():166-76. PubMed ID: 3497269 [Abstract] [Full Text] [Related]
14. Contribution of major histocompatibility complex (MHC) to upregulation of anti-DNA antibody in transgenic mice. Song YW, Tsao BP, Hahn BH. J Autoimmun; 1993 Feb 01; 6(1):1-9. PubMed ID: 8457281 [Abstract] [Full Text] [Related]
15. Correlation between the occurrence of lupus nephritis, anti-erythrocyte autoantibodies and V kappa haplotype in NZB x 129/J and NZB x SM/J recombinant inbred murine strains. Bailey NC, Bona A, Dikman S, Bonilla F, Alt FW, Bona C. Eur J Immunol; 1991 Apr 01; 21(4):959-65. PubMed ID: 1902180 [Abstract] [Full Text] [Related]
16. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice. Merino R, Iwamoto M, Fossati L, Izui S. J Immunol; 1993 Dec 01; 151(11):6509-16. PubMed ID: 7902378 [Abstract] [Full Text] [Related]
17. Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. Response correlates with the absence of an anti-antibody response. Early GS, Zhao W, Burns CM. J Immunol; 1996 Oct 01; 157(7):3159-64. PubMed ID: 8816428 [Abstract] [Full Text] [Related]
18. Defects in the regulation of anti-DNA antibody production in aged lupus-prone (NZB x NZW)F1 mice: analysis of T-cell lymphokine synthesis. Sato MN, Minoprio P, Avrameas S, Ternynck T. Immunology; 1995 May 01; 85(1):26-32. PubMed ID: 7635519 [Abstract] [Full Text] [Related]
19. Chronical administration of anti-DNA antibodies by subcutaneous injection of hybridoma clones in BALB/c and NZBxNZW/F1 mice. Experimental model of the pathogenic role of DNA in acute lupus disease. Gayral-Taminh M, Delobbe I, Mignon-Conte MA, Dueymes M, Conte JJ. J Clin Lab Immunol; 1992 May 01; 38(3):111-35. PubMed ID: 1345749 [Abstract] [Full Text] [Related]
20. Genetic studies of autoimmunity in New Zealand mice. IV. Contribution of NZB and NZW genes to the spontaneous occurrence of retroviral gp70 immune complexes in (NZB X NZW)F1 hybrid and the correlation to renal disease. Maruyama N, Furukawa F, Nakai Y, Sasaki Y, Ohta K, Ozaki S, Hirose S, Shirai T. J Immunol; 1983 Feb 01; 130(2):740-6. PubMed ID: 6217253 [Abstract] [Full Text] [Related] Page: [Next] [New Search]